GGrantIndex
Sort

130,381 grants matching hiv

HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER

$1,672,971
Saint Louis University · U01 · FY2002 · AI

PS12-1201 COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS

$1,672,521
Courtney Hampton · Arkansas State Department Of Health · U62 · FY2012 · PS

Modeling HIV Rebound: Role of SIVmac251 Functional Reservoirs and Biomarkers of Reactivation

$1,672,200
Janice Ellen Clements · Johns Hopkins University · P01 · FY2019 · AI

Mechanisms Underlying Clearance of Persistent Infections

$1,672,198
Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2014 · NS

AIDS CLINICAL TRIALS UNIT

$1,672,194
University Of Pennsylvania · U01 · FY2000 · AI

SPORE in Cervical Cancer

$1,672,035
T.-C. Wu · Johns Hopkins University · P50 · FY2023 · CA

Structure-Based Antagonism of HIV-1 Envelope Function in Cell Entry

$1,671,996
Irwin M Chaiken · Drexel University · P01 · FY2009 · GM

Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) - DOC

$1,671,972
Donald Robert Harris · Westat, Inc. · U01 · FY2016 · HD

Host Defense Against HIV-related Pulmonary Infections

$1,671,641
Judd E Shellito · Lsu Health Sciences Center · P01 · FY2013 · HL

Miami Womens Interagency HIV Study WIHS

$1,671,534
Margaret A Fischl · University Of Miami School Of Medicine · U01 · FY2017 · AI

Center for AIDS Prevention Studies

$1,670,949
Marguerita A Lightfoot · University Of California, San Francisco · P30 · FY2014 · MH

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$1,670,904
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI

Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.

$1,670,518
Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Tissue Based Small Animal Model for HIV Drug Discovery

$1,670,219
Craig Franklin · University Of California, San Francisco · N01 · FY2011 · AI

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

$1,670,008
Peter G Stock · University Of California, San Francisco · U01 · FY2015 · AI

Development of NNRTI's as Combination Microbicides

$1,669,949
Sharon L Hillier · Magee-Women'S Res Inst And Foundation · U19 · FY2006 · AI

Microbicide Safety and Acceptability in Young Men

$1,669,891
Ian Michael McGowan · Magee-Women'S Res Inst And Foundation · R01 · FY2010 · HD

SPORE in Cervical Cancer

$1,669,823
T.-C. Wu · Johns Hopkins University · P50 · FY2022 · CA

Center for AIDS Research (CFAR)

$1,669,445
Harris Goldstein · Albert Einstein College Of Medicine · P30 · FY2012 · AI

Novel Adjunctive Therapies for NeuroAIDS

$1,669,433
Harris A Gelbard · University Of Rochester · P01 · FY2007 · MH

Molecular Analysis Of Retroviral Genes And Their Products

$1,669,386
Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI

Role of Viral Reservoirs in the Pathogenesis of HIV Disease

$1,668,909
Tae-Wook Chun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI

Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP

$1,668,869
Mark Connors · Niaid Extramural Activities · Z01 · FY2007 · AI

CLINICAL PHARMACOLOGY QUALITY ASSURANCE

$1,668,783
Eugene Morse · State University Of New York At Buffalo · N01 · FY2020 · AI

SPORE in Cervical Cancer

$1,668,414
T.-C. Wu · Johns Hopkins University · P50 · FY2021 · CA